Articles From: Dr Pepper Snapple Group Declares Quarterly Dividend to Dream Global REIT Q4 2014 Financial Results Release Date, Webcast and Conference Call


Dr Pepper Snapple Group, Inc. (NYSE: DPS) today announced that its Board of Directors declared a quarterly dividend of $0.41 per share on the company’s common stock.
Sign-up for Dr Pepper Snapple Group Declares Quarterly Dividend investment picks
Dr Pepper Snapple Group (NYSE:DPS) has again been named a member of The Civic 50 , an annual initiative that identifies and recognizes companies for their commitment to improving the quality of life in the communities where they operate.
Sign-up for Dr Pepper Snapple Group Recognized as a Top Community-Minded Company for Third Consecutive Year investment picks
Dr Pepper Snapple Group, Inc. (NYSE: DPS) reported third quarter 2014 EPS of $0.96 compared to $1.01 in the prior year period.
Sign-up for Dr Pepper Snapple Group Reports Third Quarter 2014 Results investment picks
Keurig Green Mountain, Inc. (Keurig) (NASDAQ: GMCR), a leader in specialty coffee, coffee makers, teas, and other beverages with its innovative brewing technology, and Dr Pepper Snapple Group (NYSE:DPS) announced today that the companies will develop a selection of Dr Pepper Snapple Group’s iconic brands for the forthcoming Keurig Cold at-home beverage system.
Sign-up for Dr Pepper Snapple Group, Keurig to Bring Products to Keurig Cold System investment picks
2014/12/26
Dr Pepper Snapple Group leads program into Walmart with a sponsorship from ESPN and brand character ambassador Larry Culpepper PLANO, Texas , Dec.
Sign-up for Dr Pepper, Walmart Help Shoppers 'Entertain Like a Champion' for Inaugural College Football Playoffs investment picks
2014/10/23
Mercer has appointed Dr.
Sign-up for Dr. Aamir Rehman joins Mercer as Senior Physician Strategy Consultant investment picks
Magellan Health, Inc. (NASDAQ: MGLN) today announced that Dr.
Sign-up for Dr. John O. Agwunobi Appointed to Magellan Health Board of Directors investment picks
http://media.marketwire.com/attachments/201310/67642_Quidel_RGB_.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1159881&ProfileId=051205&sourceType=1 SAN DIEGO, CA --
Sign-up for Dr. Kenneth J. Widder Joins Quidel's Board of Directors investment picks
Alere Analytics , an Alere subsidiary specializing in analytics and clinical decision support (CDS) technology, today announced that Chief Executive Officer and Co-founder, Dr.
Sign-up for Dr. Mansoor Khan, CEO of Alere Analytics, to Share Vision on the Future of Big Data & Predictive Analytics at Boston Children’s Hospital Global Pediatric Innovation Summit investment picks
2015/1/21
NEW BRUNSWICK, N.J. , Jan.
Sign-up for Dr. Paul Janssen Award for Biomedical Research Issues 2015 Call for Nominations investment picks
Dr. Reddy’s Laboratories (NYSE: RDY) announced today that is has launched Docetaxel Injection USP 20 mg/mL and 80 mg/4 mL a therapeutic equivalent generic version of TAXOTERE ® (docetaxel Injection) in the US market on November 21, 2014.
Sign-up for Dr. Reddy’s Announces the Launch of Docetaxel Injection USP investment picks
Dr. Reddy’s Laboratories (NYSE: RDY) announced today that it has launched its over-the-counter (OTC) Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride Extended Release Tablets 60 mg / 120 mg, a bioequivalent generic version of Allegra-D® 12 Hour Allergy & Congestion, in the U.S. market on November 18, 2014.
Sign-up for Dr. Reddy’s Announces the Launch of Over-the-Counter Fexofenadine Hydrochloride 60 mg and Pseudoephedrine Hydrochloride 120 mg Extended-Release Tablets investment picks
Dr. Reddy’s Laboratories (NYSE: RDY) announced today that it has launched Sirolimus Tablets 1 mg and 2 mg, a therapeutic equivalent generic version of RAPAMUNE ® (Sirolimus) tablets in the US market on October 27, 2014, following the approval by the United States Food & Drug Administration (USFDA). The RAPAMUNE ® tablets brand had U.S. sales of approximately $206 Million MAT for the most recent twelve months ending in August 2014 according to IMS Health*. Dr.
Sign-up for Dr. Reddy’s Announces the Launch of Sirolimus Tablets, 1 mg and 2 mg investment picks
Dr. Reddy’s Laboratories (NYSE: RDY) announced today that it has launched Valganciclovir Tablets USP 450 mg, a therapeutic equivalent generic version of VALCYTE ® (Valganciclovir) tablets in the US market on December 15, 2014, approved by the United States Food & Drug Administration (USFDA). The VALCYTE ® (Valganciclovir) tablets brand had U.S. sales of approximately $440 Million MAT for the most recent twelve months ending in October 2014 according to IMS Health*. Dr.
Sign-up for Dr. Reddy’s Announces the Launch of Valganciclovir Tablets, USP investment picks
Dr. Reddy’s Laboratories has announced that it has closed the acquisition of Habitrol® brand (an over-the-counter nicotine replacement therapy transdermal patch) from Novartis Consumer Health Inc. following issuance of the proposed consent order from the U.S. Federal Trade Commission (FTC) on November 26, 2014.
Sign-up for Dr. Reddy’s Laboratories Closes the Acquisition of Habitrol® Brand from Novartis investment picks
Dr. Reddy’s Laboratories Ltd.
Sign-up for Dr. Reddy’s Q2 and H1 FY15 Financial Results investment picks
2014/12/2
DRA CRT Acquisition Corp.
Sign-up for DRA CRT Acquisition Corp. Announces Redemption on January 2, 2015 of Its 8-1/2% Series A Cumulative Redeemable Preferred Stock investment picks
2014/11/20
DRA CRT Acquisition Corp.
Sign-up for DRA CRT Acquisition Corp. Declares Quarterly Dividend on Preferred Stock investment picks
2015/1/16
LAS VEGAS , Jan.
Sign-up for Draft Ops Becomes Official Fantasy Gaming Partner of Bellator investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0984557001&sourceType=1 http://www.ccnmatthews.com/logos2/Drg-wave.gif OTTAWA, CANADA --
Sign-up for DragonWave Inc. to Announce Third Quarter Fiscal Year 2015 Results on January 13, 2015 investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0987312001&sourceType=1 http://www.ccnmatthews.com/logos2/Drg-wave.gif OTTAWA, CANADA --
Sign-up for DragonWave Reports Strong Third Quarter Fiscal Year 2015 Results investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0979192001&sourceType=1 http://media3.marketwire.com/logos/20140402-dream_b.png TORONTO, ONTARIO --
Sign-up for Dream Becomes National Corporate Sponsor of The Shoebox Project for Shelters(TM); Will Launch Chapters in Regina and Saskatoon investment picks
2015/1/7
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0986702001&sourceType=1 http://media3.marketwire.com/logos/20140918-DGR200.jpg TORONTO, ONTARIO --
Sign-up for Dream Global REIT Closes Joint Venture Asset Sales, Completes Reinvestment of Proceeds and Highlights Quality Office Portfolio in Newly Released Video investment picks
2014/12/17
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0984638001&sourceType=1 http://media3.marketwire.com/logos/20140918-DGR200.jpg TORONTO, ONTARIO --
Sign-up for Dream Global REIT December 2014 Monthly Distribution investment picks
2015/1/20
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0988443001&sourceType=1 http://media3.marketwire.com/logos/20140918-DGR200.jpg TORONTO, ONTARIO --
Sign-up for Dream Global REIT January 2015 Monthly Distribution investment picks
2014/11/18
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0979754001&sourceType=1 http://media3.marketwire.com/logos/20140918-DGR200.jpg TORONTO, ONTARIO --
Sign-up for Dream Global REIT November 2014 Monthly Distribution investment picks
2015/1/16
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0987924001&sourceType=1 http://media3.marketwire.com/logos/20140918-DGR200.jpg TORONTO, ONTARIO --
Sign-up for Dream Global REIT Q4 2014 Financial Results Release Date, Webcast and Conference Call investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Dr Pepper Snapple Group Declares Quarterly Dividend to Dream Global REIT Q4 2014 Financial Results Release Date, Webcast and Conference Call
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent